BioFire Defense
May 24, 2021
BioFire Defense is a specialized diagnostic company that provides a fully integrated suite of pathogen identification products. The company leads the industry in emerging infectious disease test development and is a hub for rapid PCR product innovation for bioMerieux and BioFire Diagnostics.
Recent News
- Merit Medical Acquires Biolife Delaware
- Pathos AI Secures $365 Million in Series D Financing to Advance Oncology Drug Development Through AI
- BD Launches Landmark Cell Analyzer Featuring Breakthrough Spectral and Real-Time Cell Imaging Technologies
- KyphoLift Debuts at ISMRM 2025: Transforming Patient Positioning for Safer, More Accurate Imaging
- Kelvyn Cullimore: An Unfair Penalty on Life-Saving Pills
- Merit Medical Announces Health Canada Approval of the WRAPSODY® Cell-Impermeable Endoprosthesis
